Piramal Pharma Limited (BOM:543635)
India · Delayed Price · Currency is INR 150.75
+2.00 (1.34%)
At close: Apr 21, 2026
Piramal Pharma Revenue
Piramal Pharma had revenue of 21.40B INR in the quarter ending December 31, 2025, a decrease of -2.92%. This brings the company's revenue in the last twelve months to 88.71B, down -0.87% year-over-year. In the fiscal year ending March 31, 2025, Piramal Pharma had annual revenue of 91.51B with 11.99% growth.
Revenue (ttm)
88.71B
Revenue Growth
-0.87%
P/S Ratio
2.26
Revenue / Employee
16.20M
Employees
5,476
Market Cap
200.25B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2025 | 91.51B | 9.80B | 11.99% |
| Mar 31, 2024 | 81.71B | 10.90B | 15.39% |
| Mar 31, 2023 | 70.82B | 3.47B | 5.16% |
| Mar 31, 2022 | 67.34B | 8.47B | 14.39% |
| Mar 31, 2021 | 58.87B | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Jubilant Pharmova | 79.18B |
| Granules India | 50.92B |
| J. B. Chemicals & Pharmaceuticals | 41.93B |
| GlaxoSmithKline Pharmaceuticals | 38.01B |
| AstraZeneca Pharma India | 21.77B |
| Caplin Point Laboratories | 20.92B |
| Sanofi India | 18.37B |
| Viyash Scientific | 18.17B |